Going forward, Celltrion is expected to continue its current strategy, aiming to have a total of 23 biosimilar products by 2030, covering therapeutic areas such as immunology and oncology. Leveraging ...

LANDING your dream job starts with an attention-grabbing CV – but in a competitive recruitment market many are riddled with ...

Good morning, and welcome to the day 2 of the Jefferies Healthcare Conference. My name is Dennis Ding, spec pharma analyst here at Jefferies. I have the great pleasure of having the Viatris here, the ...

Discover essential tips on navigating Cozumel prescription drugs, including what medications are available without a ...

The Nifty Pharma index is currently the top gaining sectoral index on NSE, rising over 1 percent to hover around 21,586.80.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Let’s be honest—choosing the wrong condition monitoring sensor can wreck your uptime, drain your budget, and frustrate your ...